Next Article in Journal
Conversion Surgery for Advanced Pancreatic Cancer
Previous Article in Journal
Exacerbation of Hangover Symptomology Significantly Corresponds with Heavy and Chronic Alcohol Drinking: A Pilot Study
Previous Article in Special Issue
Effect of F-18 Fluorodeoxyglucose Uptake by Bone Marrow on the Prognosis of Head and Neck Squamous Cell Carcinoma
Open AccessEditorial

Exciting Opportunities in Nuclear Medicine Imaging and Therapy

Department of Nuclear Medicine, University Hospital Augsburg, Stenglinstr. 2, 86156 Augsburg, Germany
J. Clin. Med. 2019, 8(11), 1944; https://doi.org/10.3390/jcm8111944
Received: 5 November 2019 / Accepted: 7 November 2019 / Published: 12 November 2019
(This article belongs to the Special Issue Advances in Nuclear Medicine Imaging and Therapy)
Nuclear medicine has experienced a number of unprecedented developments in recent years. Above all, the concept of “theranostics”, the combination of a predictive biomarker with a therapeutic agent, has been a central part of this success. For example, a phase III randomized, controlled trial provided unequivocal evidence of the effectiveness of 177Lu-DOTATATE for treatment of neuroendocrine tumors, and there have been multiple reports of the benefits of prostate-specific membrane antigen targeted PET imaging and radio-ligand therapy in prostate cancer. Other new exciting theranostic applications include, among many others, C-X-C motif chemokine receptor 4, as well as cancer-associated fibroblasts. These can be specifically addressed by inhibitors of the fibroblast activation protein and represent a particularly promising target for nuclear medicine theranostics. This Special Issue presents some of the most recent advances in the field of nuclear medicine. View Full-Text
Keywords: molecular imaging; theranostics; prostate-specific membrane antigen; somatostatin receptor; molecular imaging reporting and data systems molecular imaging; theranostics; prostate-specific membrane antigen; somatostatin receptor; molecular imaging reporting and data systems
MDPI and ACS Style

Lapa, C. Exciting Opportunities in Nuclear Medicine Imaging and Therapy. J. Clin. Med. 2019, 8, 1944. https://doi.org/10.3390/jcm8111944

AMA Style

Lapa C. Exciting Opportunities in Nuclear Medicine Imaging and Therapy. Journal of Clinical Medicine. 2019; 8(11):1944. https://doi.org/10.3390/jcm8111944

Chicago/Turabian Style

Lapa, Constantin. 2019. "Exciting Opportunities in Nuclear Medicine Imaging and Therapy" J. Clin. Med. 8, no. 11: 1944. https://doi.org/10.3390/jcm8111944

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop